<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE xliff PUBLIC "-//XLIFF//DTD XLIFF//EN" "http://www.oasis-open.org/committees/xliff/documents/xliff.dtd">
<xliff xmlns:logoport="urn:logoport:xliffeditor:xliff-extras:1.0" version="1.1">
	<file datatype="x-docx" logoport:revision-tracking="off" source-language="en-us" date="2024-06-25" original="C:\Users\Anthony\Downloads\ALVARE~1-Test File.docx">
		<header>
			<skl>
				<external-file href="skeleton.skl" />
			</skl>
			<tool tool-name="Logoport Generic sgml2xliff" tool-id="http://www.lionbridge.com/logoport/2005" tool-version="0.4">
				<logoport:sourceinfo>
					<logoport:source-encoding>utf-8</logoport:source-encoding>
				</logoport:sourceinfo>
			</tool>
		</header>
		<body>
			<trans-unit translate="yes" id="1">
				<source>Acute gastritis, with haemorrhage</source>
			</trans-unit>
			<trans-unit translate="yes" id="2">
				<source>ICF Version 2.0</source>
			</trans-unit>
			<trans-unit translate="yes" id="3">
				<source><bpt id="1">&lt;cf w:eastAsia="Calibri" size="12" complexscriptssize="12"&gt;</bpt>IRB APPROVED<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="4">
				<source><bpt id="1">&lt;cf w:eastAsia="Calibri" size="12" complexscriptssize="12"&gt;</bpt>AS MODIFIED<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="5">
				<source><bpt id="1">&lt;cf w:eastAsia="Calibri" size="12" complexscriptssize="12"&gt;</bpt>Aug 11, 2023<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="6">
				<source><ph id="1">&lt;separator/&gt;</ph></source>
			</trans-unit>
			<trans-unit translate="no" id="7">
				<source><ph id="1">&lt;continuationSeparator/&gt;</ph></source>
			</trans-unit>
			<trans-unit translate="no" id="8">
				<source><ph id="1">&lt;separator/&gt;</ph></source>
			</trans-unit>
			<trans-unit translate="no" id="9">
				<source><ph id="1">&lt;continuationSeparator/&gt;</ph></source>
			</trans-unit>
			<trans-unit translate="yes" id="10">
				<source><bpt id="1">&lt;cf bold="on" size="12"&gt;</bpt>TITLE:</source>
			</trans-unit>
			<trans-unit translate="no" id="11">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="yes" id="12">
				<source><ept id="1">&lt;/cf&gt;</ept><bpt id="2">&lt;cf size="12"&gt;</bpt>Flow Regulation by Opening the SepTum in Patients with Heart Failure; a prospective, randomized, sham-controlled, double blind, global multicenter study.<ept id="2">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
Blind = Blind
</note><note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
Blind = Blind
</note></trans-unit>
			<trans-unit translate="yes" id="13">
				<source><bpt id="1">&lt;cf bold="on" size="12" complexscriptssize="12"&gt;</bpt>PROTOCOL NO.:<ept id="1">&lt;/cf&gt;</ept><bpt id="2">&lt;cf size="12" complexscriptssize="12"&gt;</bpt></source>
			</trans-unit>
			<trans-unit translate="no" id="14">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="yes" id="15">
				<source>OCC2020_02<ept id="2">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="16">
				<source><bpt id="1">&lt;cf size="12" complexscriptssize="12"&gt;</bpt></source>
			</trans-unit>
			<trans-unit translate="no" id="17">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="yes" id="18">
				<source>WCG IRB Protocol #20216194<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="19">
				<source><bpt id="1">&lt;cf bold="on" size="12" complexscriptssize="12"&gt;</bpt>SPONSOR:<ept id="1">&lt;/cf&gt;</ept><bpt id="2">&lt;cf size="12" complexscriptssize="12"&gt;</bpt></source>
			</trans-unit>
			<trans-unit translate="no" id="20">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="yes" id="21">
				<source>Occlutech US LLC<ept id="2">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="22">
				<source><bpt id="1">&lt;cf bold="on" size="12" complexscriptssize="12"&gt;</bpt>INVESTIGATOR:</source>
			</trans-unit>
			<trans-unit translate="no" id="23">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="no" id="24">
				<source><ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="25">
				<source><bpt id="1">&lt;cf bold="on" size="12" complexscriptssize="12"&gt;</bpt>STUDY-RELATED<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="26">
				<source><bpt id="1">&lt;cf bold="on" size="12" complexscriptssize="12"&gt;</bpt>PHONE NUMBER(S):<ept id="1">&lt;/cf&gt;</ept><bpt id="2">&lt;cf size="12" complexscriptssize="12"&gt;</bpt></source>
			</trans-unit>
			<trans-unit translate="no" id="27">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="no" id="28">
				<source><ept id="2">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="29">
				<source>INTRODUCTION</source>
			</trans-unit>
			<trans-unit translate="yes" id="30">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>Why am I being asked to provide my consent? <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="31">
				<source>This is a research study, which is different than personal medical care. Scientists do research to answer important questions which might help change or improve the way we do things in the future.</source>
			</trans-unit>
			<trans-unit translate="no" id="32">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="33">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>Do I have to join this research study? <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="34">
				<source>No. Taking part in this research study is voluntary.</source>
			</trans-unit>
			<trans-unit translate="no" id="35">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="36">
				<source>You may choose not to take part in the study or may choose to leave the study at any time.</source>
			</trans-unit>
			<trans-unit translate="no" id="37">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="38">
				<source>Deciding not to participate, or deciding to leave the study later, will not result in any penalty or loss of benefits to which you are entitled.</source>
			</trans-unit>
			<trans-unit translate="no" id="39">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="40">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>Why is this research study being done?<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="41">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="42">
				<source>The purpose of this clinical study is to assess the safety and effectiveness of the Atrial Flow Regulator (also called the study device) in the treatment of subjects, 18 years of age or older, who have symptomatic heart failure with preserved ejection fraction (HFpEF) or heart failure with reduced ejection fraction (HFrEF) while on stable guideline directed medical therapy (GDMT) as outlined in the Guidelines for the Management of Heart Failure.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
Heart failure with preserved ejection fraction = Herzinsuffizienz mit erhaltener Auswurffraktion
Ejection fraction = Auswurffraktion
Heart failure with reduced ejection fraction = Herzinsuffizienz mit verringerter Auswurffraktion
</note><note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
Heart failure with preserved ejection fraction = Herzinsuffizienz mit erhaltener Auswurffraktion
Ejection fraction = Auswurffraktion
Heart failure with reduced ejection fraction = Herzinsuffizienz mit verringerter Auswurffraktion
</note></trans-unit>
			<trans-unit translate="yes" id="43">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>What will happen to me during the study? <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="44">
				<source>If you decide to join this research study (and are not a “roll-in” subject), you will be randomly assigned to one of three groups:</source>
			</trans-unit>
			<trans-unit translate="no" id="45">
				<source>1)</source>
			</trans-unit>
			<trans-unit translate="no" id="46">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="yes" id="47">
				<source>the investigational device group with 6 millimeter opening, 2) the investigational device with 8 millimeter opening, or 3) the sham procedure group.</source>
			</trans-unit>
			<trans-unit translate="no" id="48">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="49">
				<source>Sham procedures are like the investigational device group but the device will not actually be implanted.</source>
			</trans-unit>
			<trans-unit translate="no" id="50">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="51">
				<source>Being randomly assigned happens by chance, much like the result of flipping a coin.</source>
			</trans-unit>
			<trans-unit translate="no" id="52">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="53">
				<source>You have a one in three chance of being assigned to each group (device 6 vs. device 8 vs. sham).</source>
			</trans-unit>
			<trans-unit translate="yes" id="54">
				<source>This is blinded study, meaning that the assigned treatment group is hidden from study participants and site study staff.</source>
			</trans-unit>
			<trans-unit translate="no" id="55">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="56">
				<source>You will not know whether you were assigned to the investigational device or the sham procedure group until after you complete your 2-year (24-month) follow-up visit.</source>
			</trans-unit>
			<trans-unit translate="no" id="57">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="58">
				<source>The doctor and staff you see for follow-up visits will also be blinded to your treatment group until after your 2-year (24-month) follow-up visit.</source>
			</trans-unit>
			<trans-unit translate="yes" id="59">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>How long will I participate? <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="60">
				<source>The total study duration is expected to be about 7 years with your study participation expected to be 5 years.</source>
			</trans-unit>
			<trans-unit translate="no" id="61">
				<source> </source>
			</trans-unit>
			<trans-unit translate="no" id="62">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt> <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="63">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>Will taking part expose me to risks? <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="64">
				<source>While physicians and hospital staff will take all precautions necessary to ensure your safety and well-being, it is impossible to anticipate all potential risks/side effects.</source>
			</trans-unit>
			<trans-unit translate="no" id="65">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="66">
				<source>You will be informed about the risks related to the procedure, implantation, and examination methods by your study doctor.</source>
			</trans-unit>
			<trans-unit translate="no" id="67">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="68">
				<source>Our experience with the Atrial Flow Regulator is still limited, therefore not all risk factors are known yet.</source>
			</trans-unit>
			<trans-unit translate="no" id="69">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="70">
				<source>Reasonably foreseeable risks include excess fluid in the lungs, infections, and irregular heart rhythm.</source>
			</trans-unit>
			<trans-unit translate="no" id="71">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="72">
				<source>A more comprehensive list is included later in this form.</source>
			</trans-unit>
			<trans-unit translate="yes" id="73">
				<source>You will be carefully monitored throughout the study to identify any risks and/or side effects.</source>
			</trans-unit>
			<trans-unit translate="no" id="74">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="75">
				<source>Please inform the study doctor immediately if you notice changes in your health condition.</source>
			</trans-unit>
			<trans-unit translate="yes" id="76">
				<source>You will be notified if previously unknown risk factors become known during the duration of the study.</source>
			</trans-unit>
			<trans-unit translate="yes" id="77">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>Are there any benefits to participation? <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="78">
				<source>Having the Atrial Flow Regulator implanted may relieve some of your heart failure symptoms without open-heart surgery and you may be able to stop some medications.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
Surgery = Operativer Eingriff
</note><note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
Surgery = Operativer Eingriff
</note></trans-unit>
			<trans-unit translate="no" id="79">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="80">
				<source>Usually, the pain after the implant procedure is much less than open- heart surgery and your stay in the hospital is usually much shorter.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Pain = Schmerz
Surgery = Operativer Eingriff
</note><note annotates="Glossary" from="MedDRA 26.0">Pain = Schmerz
Surgery = Operativer Eingriff
</note></trans-unit>
			<trans-unit translate="no" id="81">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="82">
				<source>The recovery time can be faster and there is little scarring.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Scarring = Narben
</note><note annotates="Glossary" from="MedDRA 26.0">Scarring = Narben
</note></trans-unit>
			<trans-unit translate="no" id="83">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="84">
				<source>There is no guarantee that you will personally benefit from participation in this study.</source>
			</trans-unit>
			<trans-unit translate="no" id="85">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="86">
				<source>However, it is possible that the experience gained from the study can help future patients.</source>
			</trans-unit>
			<trans-unit translate="yes" id="87">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>What are my alternatives to participation?</source>
			</trans-unit>
			<trans-unit translate="no" id="88">
				<source> <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="89">
				<source>If you choose not to participate in this study at this time, your doctor will discuss alternative treatments with you.</source>
			</trans-unit>
			<trans-unit translate="no" id="90">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="91">
				<source>Treatment options may include additional medication, implantation of FDA approved devices, the use of drugs to prevent the occurrence of symptoms, or not having any treatment at all.</source>
			</trans-unit>
			<trans-unit translate="yes" id="92">
				<source>Your doctor will explain the benefits and risks associated with the implantation of the Atrial Flow Regulator and the sham procedure, as well as the alternative treatments to you.</source>
			</trans-unit>
			<trans-unit translate="no" id="93">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="94">
				<source>Please ask your doctor if you have any questions.</source>
			</trans-unit>
			<trans-unit translate="yes" id="95">
				<source>If you do not wish to take part in the study, you will receive the established treatment/ one of the alternative treatments mentioned above.</source>
			</trans-unit>
			<trans-unit translate="no" id="96">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="97">
				<source>No disadvantage of any kind shall arise for you.</source>
			</trans-unit>
			<trans-unit translate="yes" id="98">
				<source>Your doctor has told you that you have Heart Failure and that your symptoms continue despite standard of care treatment.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
</note><note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
</note></trans-unit>
			<trans-unit translate="no" id="99">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="100">
				<source>Your doctor may have performed tests to confirm your diagnosis.</source>
			</trans-unit>
			<trans-unit translate="yes" id="101">
				<source>Due to your history of heart failure and current symptoms, your doctor has invited you to participate in this research study.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
</note><note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
</note></trans-unit>
			<trans-unit translate="no" id="102">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="103">
				<source>This study compares the use of a new investigational product, the Atrial Flow Regulator (AFR) device and its delivery system, to a sham procedure.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Delivery = Entbindung
</note><note annotates="Glossary" from="MedDRA 26.0">Delivery = Entbindung
</note></trans-unit>
			<trans-unit translate="no" id="104">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="105">
				<source>A sham procedure is an inactive treatment or procedure that is intended to mimic as closely as possible the interventional procedure, but will not implant a device.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Interventional procedure = Interventionelles Verfahren
</note><note annotates="Glossary" from="MedDRA 26.0">Interventional procedure = Interventionelles Verfahren
</note></trans-unit>
			<trans-unit translate="no" id="106">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="107">
				<source>Your doctor has given you this form to tell you about this research study and to ask for your consent to join this research study.</source>
			</trans-unit>
			<trans-unit translate="no" id="108">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="109">
				<source>Your consent to join the study, if given, will be documented by your signature on the last page of this form, only after you fully understand the study.</source>
			</trans-unit>
			<trans-unit translate="yes" id="110">
				<source>The purpose of this clinical study is to assess the safety and effectiveness of the Atrial Flow Regulator (also called the study device) in the treatment of subjects, 18 years of age or older, who have symptomatic heart failure with preserved ejection fraction (HFpEF) or heart failure with reduced ejection fraction (HFrEF) while on stable guideline directed medical therapy (GDMT) as outlined in the Guidelines for the Management of Heart Failure.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
Heart failure with preserved ejection fraction = Herzinsuffizienz mit erhaltener Auswurffraktion
Ejection fraction = Auswurffraktion
Heart failure with reduced ejection fraction = Herzinsuffizienz mit verringerter Auswurffraktion
</note><note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
Heart failure with preserved ejection fraction = Herzinsuffizienz mit erhaltener Auswurffraktion
Ejection fraction = Auswurffraktion
Heart failure with reduced ejection fraction = Herzinsuffizienz mit verringerter Auswurffraktion
</note></trans-unit>
			<trans-unit translate="yes" id="111">
				<source>This study will be conducted at up to 150 centers in the U.S., Canada, Europe and Asia Pacific may participate in this study.</source>
			</trans-unit>
			<trans-unit translate="no" id="112">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="113">
				<source>Approximately 588 subjects and <ph id="1">&lt;bookmarkStart number="0" w:name="_Hlk112412543"/&gt;</ph>approximately<ph id="2">&lt;bookmarkEnd number="0"/&gt;</ph> 110 roll-in subjects will be participating in this study.</source>
			</trans-unit>
			<trans-unit translate="no" id="114">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="115">
				<source><ph id="3">&lt;bookmarkStart number="1" w:name="_Hlk112412648"/&gt;</ph>If you are part of the “roll-in” group, you<ph id="4">&lt;bookmarkEnd number="1"/&gt;</ph> will receive the AFR device (and will not be randomized to device/sham).</source>
			</trans-unit>
			<trans-unit translate="yes" id="116">
				<source>The total study duration is expected to be about 7 years with your study participation expected to be 5 years.</source>
			</trans-unit>
			<trans-unit translate="no" id="117">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="118">
				<source><ph id="1">&lt;br w:type="page"/&gt;</ph>STUDY PROCEDURE</source>
			</trans-unit>
			<trans-unit translate="yes" id="119">
				<source>If you decide to join this research study (and are not a “roll-in” subject), you will be randomly assigned to one of three groups:</source>
			</trans-unit>
			<trans-unit translate="yes" id="120">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>the investigational device group with 6 millimeter opening, 2) the investigational device with 8 millimeter opening, or 3) the sham procedure group.</source>
			</trans-unit>
			<trans-unit translate="no" id="121">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="122">
				<source>Sham procedures are like the investigational device group but the device will not actually be implanted.</source>
			</trans-unit>
			<trans-unit translate="no" id="123">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="124">
				<source>Being randomly assigned happens by chance, much like <ept id="1">&lt;/cf&gt;</ept><ph id="2">&lt;bookmarkStart number="2" w:name="_Hlk112412714"/&gt;</ph><bpt id="3">&lt;cf size="12"&gt;</bpt>the result of flipping a coin<ept id="3">&lt;/cf&gt;</ept><ph id="4">&lt;bookmarkEnd number="2"/&gt;</ph><bpt id="5">&lt;cf size="12"&gt;</bpt>.</source>
			</trans-unit>
			<trans-unit translate="no" id="125">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="126">
				<source>You have a one in three chance of being assigned to each group (device 6 vs. device 8 vs. sham).<ept id="5">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="127">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>This is blinded study, meaning that the assigned treatment group is hidden from study participants and site study staff.</source>
			</trans-unit>
			<trans-unit translate="no" id="128">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="129">
				<source>You will not know whether you were assigned to the investigational device or the sham procedure group until after you complete your 2-year (24-month) follow-up visit.</source>
			</trans-unit>
			<trans-unit translate="no" id="130">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="131">
				<source>The doctor and staff you see for follow-up visits will also be blinded to your treatment group until after your 2-year (24-month) follow-up visit.</source>
			</trans-unit>
			<trans-unit translate="no" id="132">
				<source> <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="133">
				<source><bpt id="1">&lt;cf bold="on"&gt;</bpt>Baseline Evaluation<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="134">
				<source>You will have the following tests done prior to joining in the study.</source>
			</trans-unit>
			<trans-unit translate="no" id="135">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="136">
				<source>These tests are considered standard of care and would be performed even if you did not join the study.</source>
			</trans-unit>
			<trans-unit translate="yes" id="137">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Medical history and risk factors<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="138">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>ECG<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">ECG = EKG
</note><note annotates="Glossary" from="MedDRA 26.0">ECG = EKG
</note></trans-unit>
			<trans-unit translate="yes" id="139">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Blood tests<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="140">
				<source><ph id="1">&lt;bookmarkStart number="3" w:name="_Hlk112412766"/&gt;</ph><bpt id="2">&lt;cf size="12"&gt;</bpt>Transesophageal echocardiography (TEE)<ept id="2">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Transesophageal echocardiography = Transoesophageale Echokardiographie
Echocardiography = Echokardiographie
</note><note annotates="Glossary" from="MedDRA 26.0">Transesophageal echocardiography = Transoesophageale Echokardiographie
Echocardiography = Echokardiographie
</note></trans-unit>
			<trans-unit translate="yes" id="141">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Six-minute walking test<ept id="1">&lt;/cf&gt;</ept><ph id="2">&lt;bookmarkEnd number="3"/&gt;</ph></source>
			</trans-unit>
			<trans-unit translate="yes" id="142">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>If you decide to participate in the study and sign this consent form, you will have some additional testing to make sure you are eligible for the study:</source>
			</trans-unit>
			<trans-unit translate="no" id="143">
				<source> </source>
			</trans-unit>
			<trans-unit translate="no" id="144">
				<source><ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="145">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Questionnaires about your quality of life<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="146">
				<source><bpt id="1">&lt;cf bold="on"&gt;</bpt>Device Implantation or Sham Procedure<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="147">
				<source>You will be randomly assigned to either having the Atrial Flow Regulator implanted, or having a sham procedure without having a device implanted.</source>
			</trans-unit>
			<trans-unit translate="no" id="148">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="149">
				<source>You will be required to take an anti-platelet, such as clopidogrel every day for three- months and aspirin every day for six months after the procedure.</source>
			</trans-unit>
			<trans-unit translate="no" id="150">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="151">
				<source>If you assigned to the sham procedure group, you will be given placebo (inactive) pills instead of clopidogrel and aspirin.</source>
			</trans-unit>
			<trans-unit translate="no" id="152">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="153">
				<source>The Atrial Flow Regulator is a self-expandable, double disc device made from a wire mesh.</source>
			</trans-unit>
			<trans-unit translate="no" id="154">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="155">
				<source>The two discs are linked together by a short connecting waist.</source>
			</trans-unit>
			<trans-unit translate="no" id="156">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="157">
				<source>Each device has a hole (shunt) of either 6 millimeters or 8 millimeters diameter (width).</source>
			</trans-unit>
			<trans-unit translate="no" id="158">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="159">
				<source>The materials used in the in the device are the same as that used by surgeons for other cardiac treatments.</source>
			</trans-unit>
			<trans-unit translate="no" id="160">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="161">
				<source>The Atrial Flow Regulator will remain implanted in your heart.</source>
			</trans-unit>
			<trans-unit translate="no" id="162">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="163">
				<source>The sham procedure will allow the surgeon to take detailed measurements of your heart function, but no devices or therapy will be administered.</source>
			</trans-unit>
			<trans-unit translate="no" id="164">
				<source> </source>
			</trans-unit>
			<trans-unit translate="no" id="165">
				<source><ph id="1">&lt;w:drawing complexscriptsfont="Arial" size="11" complexscriptssize="11"/&gt;</ph></source>
			</trans-unit>
			<trans-unit translate="yes" id="166">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on" fontcolor="auto"&gt;</bpt>Figure <ept id="1">&lt;/cf&gt;</ept><ph id="2">&lt;field Id="1" text="SEQ"/&gt;</ph><bpt id="3">&lt;cf bold="on" complexscriptsbold="on" fontcolor="auto"&gt;</bpt>:</source>
			</trans-unit>
			<trans-unit translate="no" id="167">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="168">
				<source>Atrial Flow Regulator<ept id="3">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="169">
				<source>You will have either procedure in the cardiac catheterization laboratory, or “cath lab”, or a procedure room.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Cardiac catheterization = Herzkatheterisierung
</note><note annotates="Glossary" from="MedDRA 26.0">Cardiac catheterization = Herzkatheterisierung
</note></trans-unit>
			<trans-unit translate="no" id="170">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="171">
				<source>Local or general anesthesia will be used and there should not be significant discomfort.</source>
			<note annotates="Glossary" from="MedDRA 26.0">General anesthesia = Allgemeine Anaesthesie
Anesthesia = Ausgeschaltetes Schmerzempfinden
Discomfort = Unbehagen
</note><note annotates="Glossary" from="MedDRA 26.0">General anesthesia = Allgemeine Anaesthesie
Anesthesia = Ausgeschaltetes Schmerzempfinden
Discomfort = Unbehagen
</note></trans-unit>
			<trans-unit translate="no" id="172">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="173">
				<source>This is a non-surgical, minimally invasive procedure done using <ph id="1">&lt;bookmarkStart number="4" w:name="_Hlk112412827"/&gt;</ph>echocardiography<ph id="2">&lt;bookmarkEnd number="4"/&gt;</ph> guidance in which a catheter is inserted through a blood vessel in your thigh up into your heart.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Invasive procedure = Invasives Verfahren
Echocardiography = Echokardiographie
</note><note annotates="Glossary" from="MedDRA 26.0">Invasive procedure = Invasives Verfahren
Echocardiography = Echokardiographie
</note></trans-unit>
			<trans-unit translate="no" id="174">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="175">
				<source>A catheter is a sterile, flexible, hollow tube that is inserted into a blood vessel to allow for injection or removal of fluids or to pass devices through.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Injection = Injektion
</note><note annotates="Glossary" from="MedDRA 26.0">Injection = Injektion
</note></trans-unit>
			<trans-unit translate="no" id="176">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="177">
				<source>After the procedure, you may experience some discomfort in the area where the catheter was inserted.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Discomfort = Unbehagen
</note><note annotates="Glossary" from="MedDRA 26.0">Discomfort = Unbehagen
</note></trans-unit>
			<trans-unit translate="yes" id="178">
				<source>To help your doctor evaluate your heart during the procedure, you will have a Transesophageal Echocardiography (TEE) or Intracardiac Echocardiography (ICE).</source>
			<note annotates="Glossary" from="MedDRA 26.0">Transesophageal echocardiography = Transoesophageale Echokardiographie
Echocardiography = Echokardiographie
</note><note annotates="Glossary" from="MedDRA 26.0">Transesophageal echocardiography = Transoesophageale Echokardiographie
Echocardiography = Echokardiographie
</note></trans-unit>
			<trans-unit translate="no" id="179">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="180">
				<source>The TEE is an ultrasound test to see your heart, where an imaging probe is placed through your mouth and passed into your esophagus.</source>
			</trans-unit>
			<trans-unit translate="no" id="181">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="182">
				<source>Some soreness may persist in your throat for about one week.</source>
			</trans-unit>
			<trans-unit translate="no" id="183">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="184">
				<source>If your doctor decides to look at your heart using ICE, the doctor will pass an ICE imaging probe through a blood vessel in your thigh up into your heart.</source>
			</trans-unit>
			<trans-unit translate="yes" id="185">
				<source>After your doctor has accessed your heart and measured your heart pressures, the doctor will make sure you meet the criteria to be included in the study.</source>
			</trans-unit>
			<trans-unit translate="no" id="186">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="187">
				<source>If you meet criteria, you will be randomly assigned to receive the AFR with 6mm hole, AFR with 8mm hole, or sham procedure.</source>
			</trans-unit>
			<trans-unit translate="no" id="188">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="189">
				<source>If you do not meet criteria, you will not be included in the study and your doctor will continue to treat you according to standard of care.</source>
			</trans-unit>
			<trans-unit translate="no" id="190">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="191">
				<source>If you are randomized to the AFR device with either the 6mm or 8mm hole, the study procedure will be the same.</source>
			</trans-unit>
			<trans-unit translate="no" id="192">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="193">
				<source>A standard guidewire will be used to access the right side of your heart through a large vein in your upper leg.</source>
			</trans-unit>
			<trans-unit translate="no" id="194">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="195">
				<source>A catheter will be placed over the wire in the same fashion.</source>
			</trans-unit>
			<trans-unit translate="no" id="196">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="197">
				<source>Your doctor will then create a hole in the atrial septum, the tissue that separates the left side of the heart from the right side.</source>
			</trans-unit>
			<trans-unit translate="no" id="198">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="199">
				<source>Once there is a connection from right to left, the AFR device is passed through the catheter and positioned in the middle of your left atrium.</source>
			</trans-unit>
			<trans-unit translate="no" id="200">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="201">
				<source>The left disk is deployed, and then drawn against the atrial septum.</source>
			</trans-unit>
			<trans-unit translate="no" id="202">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="203">
				<source>The right disc is then deployed.</source>
			</trans-unit>
			<trans-unit translate="no" id="204">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="205">
				<source>After your doctor is satisfied with the position of the device, it is released from the delivery cable using a screw mechanism.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Delivery = Entbindung
</note><note annotates="Glossary" from="MedDRA 26.0">Delivery = Entbindung
</note></trans-unit>
			<trans-unit translate="no" id="206">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="207">
				<source>The duration of the procedure will be about 1-2 hours but can vary depending on needs.</source>
			</trans-unit>
			<trans-unit translate="no" id="208">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="209">
				<source>There will be a sponsor representative present at cases to support the study doctor during implant.</source>
			</trans-unit>
			<trans-unit translate="yes" id="210">
				<source>If you are randomized to the sham procedure, you will have the same wire and catheter access to the right side of your heart.</source>
			</trans-unit>
			<trans-unit translate="no" id="211">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="212">
				<source>Heart pressures will be measured, but no hole will be created in the tissue that separates the right and left side of your heart and no device will be implanted.</source>
			</trans-unit>
			<trans-unit translate="no" id="213">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="214">
				<source>After recovery from sedation or anesthesia and a few hours of bed rest, you should be able to sit up and walk around.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Sedation = Sedierung
Anesthesia = Ausgeschaltetes Schmerzempfinden
Bed rest = Bettruhe
</note><note annotates="Glossary" from="MedDRA 26.0">Sedation = Sedierung
Anesthesia = Ausgeschaltetes Schmerzempfinden
Bed rest = Bettruhe
</note></trans-unit>
			<trans-unit translate="no" id="215">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="216">
				<source>Before you are discharged from the hospital, an electrocardiogram (ECG) and physical exam will be done to assess if you are well enough to go home.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Electrocardiogram = Elektrokardiogramm
ECG = EKG
</note><note annotates="Glossary" from="MedDRA 26.0">Electrocardiogram = Elektrokardiogramm
ECG = EKG
</note></trans-unit>
			<trans-unit translate="no" id="217">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="218">
				<source>After you are sent home, you will be required to take clopidogrel every day for three months and aspirin every day for six months after the procedure to make sure no blood clots form on your device.</source>
			</trans-unit>
			<trans-unit translate="no" id="219">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="220">
				<source>You may already be taking an anti-platelet such as clopidogrel and aspirin for other reasons.</source>
			</trans-unit>
			<trans-unit translate="no" id="221">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="222">
				<source>Your doctor may decide to keep you on clopidogrel and aspirin after the required six months if it is in your best interest.</source>
			</trans-unit>
			<trans-unit translate="no" id="223">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="224">
				<source>If you had the sham procedure, your doctor may prescribe placebo (sugar pills) instead of clopidogrel and aspirin.</source>
			</trans-unit>
			<trans-unit translate="no" id="225">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="226">
				<source>To prevent against certain bacterial infections, you may need to take some doses of an antibiotic during the first six months following the placement of the device, especially if you are planning to undergo certain procedures such as dental cleanings.</source>
			</trans-unit>
			<trans-unit translate="no" id="227">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="228">
				<source>All patients will receive a patient card with information about their procedure <ph id="1">&lt;bookmarkStart number="5" w:name="_Hlk112412916"/&gt;</ph>regardless if<ph id="2">&lt;bookmarkEnd number="5"/&gt;</ph> they were randomly selected to receive the implanted device or the sham procedure.</source>
			</trans-unit>
			<trans-unit translate="no" id="229">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="230">
				<source>The patient card will also have the contact details to the study hospital.</source>
			</trans-unit>
			<trans-unit translate="no" id="231">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="232">
				<source><ph id="3">&lt;bookmarkStart number="6" w:name="_Hlk112412941"/&gt;</ph>Since you are in a blinded study, you should show this card to medical staff to inform them to keep you blinded if you have a chest x-ray or other assessment that could possibly unblind you.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Chest X-ray = Roentgen Thorax
X-ray = Roentgen
</note><note annotates="Glossary" from="MedDRA 26.0">Chest X-ray = Roentgen Thorax
X-ray = Roentgen
</note></trans-unit>
			<trans-unit translate="no" id="233">
				<source> <ph id="4">&lt;bookmarkEnd number="6"/&gt;</ph></source>
			</trans-unit>
			<trans-unit translate="yes" id="234">
				<source>Following your discharge there will be several follow up visits.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Discharge = Absonderung
</note><note annotates="Glossary" from="MedDRA 26.0">Discharge = Absonderung
</note></trans-unit>
			<trans-unit translate="no" id="235">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="236">
				<source>You will be asked to come for your study visits at 1-, 6-, 12- and 24-months after your procedure.</source>
			</trans-unit>
			<trans-unit translate="no" id="237">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="238">
				<source>Some of the assessments at these visits include a clinical assessment and physical exam, a six (6) minute walk test, ECG, laboratory, medication and adverse event assessments and study questionnaires.</source>
			<note annotates="Glossary" from="MedDRA 26.0">ECG = EKG
Adverse event = Unerwuenschtes Ereignis
</note><note annotates="Glossary" from="MedDRA 26.0">ECG = EKG
Adverse event = Unerwuenschtes Ereignis
</note></trans-unit>
			<trans-unit translate="yes" id="239">
				<source>After your 2-year (24-month) follow-up visit, you will be told whether you received the AFR device or the sham procedure.</source>
			</trans-unit>
			<trans-unit translate="no" id="240">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="241">
				<source>If you had the sham procedure, you will be given the option to “cross-over” and receive the AFR device implant after the 2-year (24-month) follow-up visit.</source>
			</trans-unit>
			<trans-unit translate="no" id="242">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="243">
				<source>If you would like to have the AFR device implanted, your study doctor will evaluate your symptoms and make sure you still meet all criteria.</source>
			</trans-unit>
			<trans-unit translate="no" id="244">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="245">
				<source>If you meet all criteria, your procedure will be scheduled and will be completed as described above.</source>
			</trans-unit>
			<trans-unit translate="no" id="246">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="247">
				<source>Patients that elect to have the AFR device implanted after their 2-year (24-month) follow-up visit will be followed until they have been in the study for a total of 5 years.</source>
			</trans-unit>
			<trans-unit translate="no" id="248">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="249">
				<source>These follow-up visits occurring after the cross-over AFR implant include a 6-month, 12-month and annual visit until total study participation has reached 5 years (60-months).</source>
			</trans-unit>
			<trans-unit translate="no" id="250">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="251">
				<source>The assessments completed during these visits are similar to the assessments you completed during the first two years of the study.</source>
			</trans-unit>
			<trans-unit translate="no" id="252">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="253">
				<source>Once you have completed your follow-up visits as part of the investigational study, you will be given the option to participate in a post-approval study that will collect long term safety and efficacy data.</source>
			</trans-unit>
			<trans-unit translate="yes" id="254">
				<source>WHAT WE EXPECT FROM YOU</source>
			</trans-unit>
			<trans-unit translate="yes" id="255">
				<source>You are requested to be available for all scheduled appointments at the study site.</source>
			</trans-unit>
			<trans-unit translate="no" id="256">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="257">
				<source>Please report all changes in your physical health to the study doctor.</source>
			</trans-unit>
			<trans-unit translate="no" id="258">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="259">
				<source>Also, all medication you are taking during the study, both prescription and non-prescription drugs must be disclosed to the study doctor.</source>
			</trans-unit>
			<trans-unit translate="yes" id="260">
				<source>Please follow all the instructions of the study doctor and their medical staff carefully.<bpt id="1">&lt;cf style="normaltextrun"&gt;</bpt></source>
			</trans-unit>
			<trans-unit translate="no" id="261">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="262">
				<source>Tell your study doctor if you become aware of your randomization assignment (device vs sham) during the first two years of your study participation.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="263">
				<source><bpt id="1">&lt;cf style="normaltextrun"&gt;</bpt>Because you are in this clinical investigation, you may need to visit your doctor more frequently than standard of care, which may be an inconvenience to you.<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Investigation = Untersuchung
</note><note annotates="Glossary" from="MedDRA 26.0">Investigation = Untersuchung
</note></trans-unit>
			<trans-unit translate="yes" id="264">
				<source>FORESEEABLE RISKS AND SIDE EFFECTS</source>
			</trans-unit>
			<trans-unit translate="yes" id="265">
				<source>While physicians and hospital staff will take all precautions necessary to ensure your safety and well-being, it is impossible to anticipate all potential risks/side effects.</source>
			</trans-unit>
			<trans-unit translate="no" id="266">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="267">
				<source>You will be informed about the risks related to the procedure, implantation, and examination methods by your study doctor.</source>
			</trans-unit>
			<trans-unit translate="no" id="268">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="269">
				<source>Our experience with the Atrial Flow Regulator is still limited, therefore not all risk factors are known yet.</source>
			</trans-unit>
			<trans-unit translate="no" id="270">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="271">
				<source>You will be carefully monitored throughout the study to identify any risks and/or side effects.</source>
			</trans-unit>
			<trans-unit translate="no" id="272">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="273">
				<source>Please inform the study doctor immediately if you notice changes in your health condition.</source>
			</trans-unit>
			<trans-unit translate="yes" id="274">
				<source>You will be notified if previously unknown risk factors become known during the duration of the study.</source>
			</trans-unit>
			<trans-unit translate="yes" id="275">
				<source>The implantation of the Atrial Flow Regulator may cause undesired side effects and discomfort.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Discomfort = Unbehagen
</note><note annotates="Glossary" from="MedDRA 26.0">Discomfort = Unbehagen
</note></trans-unit>
			<trans-unit translate="no" id="276">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="277">
				<source>The rates of previously observed adverse events and complaints with Atrial Flow Regulator and catheter-based implant methods are low.</source>
			</trans-unit>
			<trans-unit translate="no" id="278">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="279">
				<source>However, problems may occur, which the doctor will discuss and assess with you.</source>
			</trans-unit>
			<trans-unit translate="yes" id="280">
				<source><ph id="1">&lt;br w:type="page"/&gt;</ph>The following device and procedural risks are listed according to the expected frequency of occurrence based on available data:</source>
			</trans-unit>
			<trans-unit translate="yes" id="281">
				<source><bpt id="1">&lt;cf complexscriptsfont="Arial" bold="on" complexscriptsbold="on" size="12" complexscriptssize="12"&gt;</bpt>Symbol<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="282">
				<source><bpt id="1">&lt;cf complexscriptsfont="Arial" bold="on" complexscriptsbold="on" size="12" complexscriptssize="12"&gt;</bpt>Meaning<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="283">
				<source><bpt id="1">&lt;cf complexscriptsfont="Arial" size="12" complexscriptssize="12"&gt;</bpt>&lt; <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="284">
				<source><bpt id="1">&lt;cf complexscriptsfont="Arial" size="12" complexscriptssize="12"&gt;</bpt>less than<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="285">
				<source><bpt id="1">&lt;cf complexscriptsfont="Arial" size="12" complexscriptssize="12"&gt;</bpt>≤ <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="286">
				<source><bpt id="1">&lt;cf complexscriptsfont="Arial" size="12" complexscriptssize="12"&gt;</bpt>less than or equal to<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="287">
				<source><bpt id="1">&lt;cf complexscriptsfont="Arial" size="12" complexscriptssize="12"&gt;</bpt>&gt; <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="288">
				<source><bpt id="1">&lt;cf complexscriptsfont="Arial" size="12" complexscriptssize="12"&gt;</bpt>greater than<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="289">
				<source><bpt id="1">&lt;cf complexscriptsfont="Arial" size="12" complexscriptssize="12"&gt;</bpt>≥ <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="290">
				<source><bpt id="1">&lt;cf complexscriptsfont="Arial" size="12" complexscriptssize="12"&gt;</bpt>greater than or equal to <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="291">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>Frequent (&gt;5% to 10%):<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="292">
				<source>Excess fluid in the lungs</source>
			</trans-unit>
			<trans-unit translate="yes" id="293">
				<source>Infections, including a bacterial infection of the inner layer of the heart or the heart valves</source>
			<note annotates="Glossary" from="MedDRA 26.0">Bacterial infection = Bakterielle Infektion
Infection = Infektion
</note><note annotates="Glossary" from="MedDRA 26.0">Bacterial infection = Bakterielle Infektion
Infection = Infektion
</note></trans-unit>
			<trans-unit translate="yes" id="294">
				<source>Irregular heart rhythm</source>
			</trans-unit>
			<trans-unit translate="yes" id="295">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>Occasional (&gt;2% to 5%):<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="296">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Bleeding, hemorrhage, or bruising requiring treatment<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Bleeding = Bluten
Hemorrhage = Blutung
Bruising = Blaue Flecken
</note><note annotates="Glossary" from="MedDRA 26.0">Bleeding = Bluten
Hemorrhage = Blutung
Bruising = Blaue Flecken
</note></trans-unit>
			<trans-unit translate="yes" id="297">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Blood clot that blocks veins or arteries<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="298">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Bruise which happens when blood collects/pools under the skin<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Bruise = Blauer Fleck
</note><note annotates="Glossary" from="MedDRA 26.0">Bruise = Blauer Fleck
</note></trans-unit>
			<trans-unit translate="yes" id="299">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Chest pain<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Chest pain = Brustkorbschmerz
Pain = Schmerz
</note><note annotates="Glossary" from="MedDRA 26.0">Chest pain = Brustkorbschmerz
Pain = Schmerz
</note></trans-unit>
			<trans-unit translate="yes" id="300">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Death<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Death = Tod
</note><note annotates="Glossary" from="MedDRA 26.0">Death = Tod
</note></trans-unit>
			<trans-unit translate="yes" id="301">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Fluid collects in the sac surrounding the heart which puts pressure on the heart and may prevent it from pumping well<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="302">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Injury to the artery, vein or nerves in the groin or neck needing surgical repair<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
</note><note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
</note></trans-unit>
			<trans-unit translate="yes" id="303">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Severe drop in oxygen saturation and sudden or gradual onset of the signs and symptoms of heart failure<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Oxygen saturation = Sauerstoffsaettigung
Heart failure = Kardiales Versagen
</note><note annotates="Glossary" from="MedDRA 26.0">Oxygen saturation = Sauerstoffsaettigung
Heart failure = Kardiales Versagen
</note></trans-unit>
			<trans-unit translate="yes" id="304">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Severe pain in the chest, often also spreading to the shoulders, arms, and neck, caused by an inadequate blood supply to the heart<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Pain = Schmerz
</note><note annotates="Glossary" from="MedDRA 26.0">Pain = Schmerz
</note></trans-unit>
			<trans-unit translate="yes" id="305">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Shortness of breath<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Shortness of breath = Kurzatmigkeit
</note><note annotates="Glossary" from="MedDRA 26.0">Shortness of breath = Kurzatmigkeit
</note></trans-unit>
			<trans-unit translate="yes" id="306">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Worsening heart failure (right and left), worsening of function of the right ventricle of the heart<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
</note><note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
</note></trans-unit>
			<trans-unit translate="yes" id="307">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>Remote (&gt; 0.2% -to 2%):<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="308">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Air around or outside the lung<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="309">
				<source>A blood clot that moves through the device (i.e., paradoxical embolus or thrombus formation on the device), potentially leading to a stroke</source>
			<note annotates="Glossary" from="MedDRA 26.0">Embolus = Embolus
Thrombus = Thrombus
Stroke = Schlaganfall
</note><note annotates="Glossary" from="MedDRA 26.0">Embolus = Embolus
Thrombus = Thrombus
Stroke = Schlaganfall
</note></trans-unit>
			<trans-unit translate="yes" id="310">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Deficiency of red blood cells or of hemoglobin in the blood, resulting in fatigue<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Hemoglobin = Haemoglobin
Fatigue = Ermuedung
</note><note annotates="Glossary" from="MedDRA 26.0">Hemoglobin = Haemoglobin
Fatigue = Ermuedung
</note></trans-unit>
			<trans-unit translate="yes" id="311">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Excess fluid in the legs or arms<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="312">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Excess fluid in the space around the heart<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="313">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Fainting<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Fainting = Bewusstlos werden
</note><note annotates="Glossary" from="MedDRA 26.0">Fainting = Bewusstlos werden
</note></trans-unit>
			<trans-unit translate="yes" id="314">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Low or high blood pressure<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Blood pressure = Blutdruck
</note><note annotates="Glossary" from="MedDRA 26.0">Blood pressure = Blutdruck
</note></trans-unit>
			<trans-unit translate="yes" id="315">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Device Embolization (Movement of the device to an unintended location with resulting obstruction of an organ or vessel)<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Device embolization = Embolisation bedingt durch Medizinprodukt
Obstruction = Obstruktion
</note><note annotates="Glossary" from="MedDRA 26.0">Device embolization = Embolisation bedingt durch Medizinprodukt
Obstruction = Obstruktion
</note></trans-unit>
			<trans-unit translate="yes" id="316">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Paresthesia (an abnormal sensation, typically tingling or pricking (“pins and needles”), caused chiefly by pressure on or damage to nerves)<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Paresthesia = Paraesthesie
Tingling = Kribbeln
Pins and needles = Nadelstiche
</note><note annotates="Glossary" from="MedDRA 26.0">Paresthesia = Paraesthesie
Tingling = Kribbeln
Pins and needles = Nadelstiche
</note></trans-unit>
			<trans-unit translate="yes" id="317">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Re-intervention or surgical intervention (an invasive technique to treat, take action, or prevent disease or improve health)<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Surgical intervention = Operative Intervention
</note><note annotates="Glossary" from="MedDRA 26.0">Surgical intervention = Operative Intervention
</note></trans-unit>
			<trans-unit translate="yes" id="318">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Sepsis (a potentially life-threatening condition that occurs when the body's response to an infection damages its own tissues)<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Sepsis = Sepsis
Infection = Infektion
</note><note annotates="Glossary" from="MedDRA 26.0">Sepsis = Sepsis
Infection = Infektion
</note></trans-unit>
			<trans-unit translate="yes" id="319">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Stroke<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Stroke = Schlaganfall
</note><note annotates="Glossary" from="MedDRA 26.0">Stroke = Schlaganfall
</note></trans-unit>
			<trans-unit translate="yes" id="320">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Vomiting<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Vomiting = Erbrechen
</note><note annotates="Glossary" from="MedDRA 26.0">Vomiting = Erbrechen
</note></trans-unit>
			<trans-unit translate="yes" id="321">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on" size="12"&gt;</bpt>Unknown frequency; expected to be rare/highly unlikely:<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="322">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Allergic reactions<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="323">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>An abnormal connection between an artery and a vein<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="324">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>An injury to the nerves that send signals from the spinal cord to the shoulder, arm, and hand<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
</note><note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
</note></trans-unit>
			<trans-unit translate="yes" id="325">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Cardiac / vascular perforation (a small hole in the heart tissue or blood vessels)<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Perforation = Perforation
</note><note annotates="Glossary" from="MedDRA 26.0">Perforation = Perforation
</note></trans-unit>
			<trans-unit translate="yes" id="326">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Deprivation of oxygen<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="327">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Headache, including migraine, neck or head pain<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Headache = Kopfschmerzen
Migraine = Migraene
Head pain = Kopfschmerz
Pain = Schmerz
</note><note annotates="Glossary" from="MedDRA 26.0">Headache = Kopfschmerzen
Migraine = Migraene
Head pain = Kopfschmerz
Pain = Schmerz
</note></trans-unit>
			<trans-unit translate="yes" id="328">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Heart attack<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Heart attack = Herzanfall
</note><note annotates="Glossary" from="MedDRA 26.0">Heart attack = Herzanfall
</note></trans-unit>
			<trans-unit translate="yes" id="329">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Injury to blood vessel wall and the leaking blood collects in the surrounding tissue<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
</note><note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
</note></trans-unit>
			<trans-unit translate="yes" id="330">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Injury of the esophagus (from the use of the TEE probe) or heart<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
</note><note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
</note></trans-unit>
			<trans-unit translate="yes" id="331">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Leakage of air into the veins, or heart<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="332">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Pacemaker insertion secondary to device placement<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="333">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Pacing device malfunction, valve dysfunction or difficulty to exchange pacing lead associated with pacing lead or pacemaker entrapment<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Device malfunction = Funktionsstoerung eines Medizinprodukts
Lead = Blei
</note><note annotates="Glossary" from="MedDRA 26.0">Device malfunction = Funktionsstoerung eines Medizinprodukts
Lead = Blei
</note></trans-unit>
			<trans-unit translate="yes" id="334">
				<source>Pulmonary hypertension, which occurs when the pressure in blood vessels leading from the heart to the lungs is too high</source>
			<note annotates="Glossary" from="MedDRA 26.0">Pulmonary hypertension = Pulmonale Hypertonie
Hypertension = Hypertonie
</note><note annotates="Glossary" from="MedDRA 26.0">Pulmonary hypertension = Pulmonale Hypertonie
Hypertension = Hypertonie
</note></trans-unit>
			<trans-unit translate="yes" id="335">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Seizure<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Seizure = Krampfanfall
</note><note annotates="Glossary" from="MedDRA 26.0">Seizure = Krampfanfall
</note></trans-unit>
			<trans-unit translate="yes" id="336">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Swelling/irritation of the thin saclike membrane surrounding the heart<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Swelling = Schwellung
</note><note annotates="Glossary" from="MedDRA 26.0">Swelling = Schwellung
</note></trans-unit>
			<trans-unit translate="yes" id="337">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Temporary cessation of breathing<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="338">
				<source><bpt id="1">&lt;cf size="12" complexscriptssize="12"&gt;</bpt>There are also risks associated with the use of anesthesia.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Anesthesia = Ausgeschaltetes Schmerzempfinden
</note><note annotates="Glossary" from="MedDRA 26.0">Anesthesia = Ausgeschaltetes Schmerzempfinden
</note></trans-unit>
			<trans-unit translate="no" id="339">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="340">
				<source><ept id="1">&lt;/cf&gt;</ept><bpt id="2">&lt;cf complexscriptsbold="on" size="12" complexscriptssize="12"&gt;</bpt>Common side effects of general anesthesia include nausea and vomiting, dry mouth, sore throat or hoarseness, chills, confusion, dizziness, muscle aches, itching and difficulty urinating.</source>
			<note annotates="Glossary" from="MedDRA 26.0">General anesthesia = Allgemeine Anaesthesie
Anesthesia = Ausgeschaltetes Schmerzempfinden
Nausea = Uebelkeit
Vomiting = Erbrechen
Dry mouth = Mundtrockenheit
Sore throat = Rauer Hals
Hoarseness = Heiserkeit
Chills = Schuettelfrost
Confusion = Verwirrtheit
Dizziness = Schwindelgefuehl
Itching = Jucken
</note><note annotates="Glossary" from="MedDRA 26.0">General anesthesia = Allgemeine Anaesthesie
Anesthesia = Ausgeschaltetes Schmerzempfinden
Nausea = Uebelkeit
Vomiting = Erbrechen
Dry mouth = Mundtrockenheit
Sore throat = Rauer Hals
Hoarseness = Heiserkeit
Chills = Schuettelfrost
Confusion = Verwirrtheit
Dizziness = Schwindelgefuehl
Itching = Jucken
</note></trans-unit>
			<trans-unit translate="no" id="341">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="342">
				<source>Serious, life threatening side effects such as heart rhythm disturbances, strokes or accidents causing brain damage can occur.<ept id="2">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Brain damage = Hirnschaden
</note><note annotates="Glossary" from="MedDRA 26.0">Brain damage = Hirnschaden
</note></trans-unit>
			<trans-unit translate="yes" id="343">
				<source>Tissue or device erosion (wearing down)</source>
			</trans-unit>
			<trans-unit translate="yes" id="344">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Trans Ischemic Attack (TIA) (a temporary period of symptoms similar to those of a stroke)<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">TIA = TIA
Stroke = Schlaganfall
</note><note annotates="Glossary" from="MedDRA 26.0">TIA = TIA
Stroke = Schlaganfall
</note></trans-unit>
			<trans-unit translate="yes" id="345">
				<source><ph id="1">&lt;br w:type="page"/&gt;</ph><bpt id="2">&lt;cf size="12"&gt;</bpt>Valvular regurgitation (heart valve does not close properly)<ept id="2">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Regurgitation = Regurgitation
</note><note annotates="Glossary" from="MedDRA 26.0">Regurgitation = Regurgitation
</note></trans-unit>
			<trans-unit translate="yes" id="346">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Worsening or new formation of excess fluid in the heart or lungs mostly 1 to 6 weeks after cardiac surgery<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Surgery = Operativer Eingriff
</note><note annotates="Glossary" from="MedDRA 26.0">Surgery = Operativer Eingriff
</note></trans-unit>
			<trans-unit translate="yes" id="347">
				<source>Because the Atrial Flow Regulator device is new there may be other risks that are not known at this time.</source>
			</trans-unit>
			<trans-unit translate="no" id="348">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="349">
				<source>Clopidogrel and aspirin are drugs that thin your blood and may prevent clots from forming on your device.</source>
			</trans-unit>
			<trans-unit translate="no" id="350">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="351">
				<source>Reported risks associated with medicine (aspirin and clopidogrel) used after implantation of the Atrial Flow Regulator to thin the blood include, but are not limited to, increased bleeding time, gastrointestinal (GI) bleeding, drowsiness, dizziness, headache, nausea and vomiting, rash, and bruising.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Bleeding = Bluten
Bleeding time = Blutungszeit
Drowsiness = Benommenheit
Dizziness = Schwindelgefuehl
Headache = Kopfschmerzen
Nausea = Uebelkeit
Vomiting = Erbrechen
Rash = Ausschlag
Bruising = Blaue Flecken
</note><note annotates="Glossary" from="MedDRA 26.0">Bleeding = Bluten
Bleeding time = Blutungszeit
Drowsiness = Benommenheit
Dizziness = Schwindelgefuehl
Headache = Kopfschmerzen
Nausea = Uebelkeit
Vomiting = Erbrechen
Rash = Ausschlag
Bruising = Blaue Flecken
</note></trans-unit>
			<trans-unit translate="no" id="352">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="353">
				<source>There may be other risks related to these medicines used to thin the blood that are unknown at this time.</source>
			</trans-unit>
			<trans-unit translate="yes" id="354">
				<source>There may be risks associated with trying to remove the AFR device.</source>
			</trans-unit>
			<trans-unit translate="no" id="355">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="356">
				<source>Once the device is implanted, an already implanted Atrial Flow Regulator can only be removed for clear medical reasons.</source>
			</trans-unit>
			<trans-unit translate="no" id="357">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="358">
				<source>Cardiac surgery following device placement may be more difficult.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Surgery = Operativer Eingriff
</note><note annotates="Glossary" from="MedDRA 26.0">Surgery = Operativer Eingriff
</note></trans-unit>
			<trans-unit translate="yes" id="359">
				<source>If you are in the sham procedure group, there may be risks of delaying treatment including worsening heart failure.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
</note><note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
</note></trans-unit>
			<trans-unit translate="yes" id="360">
				<source>In addition to the known risks above, because this treatment or procedure has not been studied in pregnant women, there may be additional risks to you (or to your embryo or fetus, if you are or may become pregnant, or are nursing an infant) which are unknown at this time.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Pregnant = Schwanger
Infant = Saeugling
</note><note annotates="Glossary" from="MedDRA 26.0">Pregnant = Schwanger
Infant = Saeugling
</note></trans-unit>
			<trans-unit translate="no" id="361">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="362">
				<source><ph id="1">&lt;bookmarkStart number="7" w:name="_Hlk112413568"/&gt;</ph>If you are pregnant or plan to become pregnant during the study, you will not be able to participate.<ph id="2">&lt;bookmarkEnd number="7"/&gt;</ph></source>
			<note annotates="Glossary" from="MedDRA 26.0">Pregnant = Schwanger
</note><note annotates="Glossary" from="MedDRA 26.0">Pregnant = Schwanger
</note></trans-unit>
			<trans-unit translate="no" id="363">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="364">
				<source>Notify your doctor immediately if you become pregnant while taking part in this study.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Pregnant = Schwanger
</note><note annotates="Glossary" from="MedDRA 26.0">Pregnant = Schwanger
</note></trans-unit>
			<trans-unit translate="yes" id="365">
				<source>EXPECTED IMPACT AND BENEFITS</source>
			</trans-unit>
			<trans-unit translate="yes" id="366">
				<source>Having the Atrial Flow Regulator implanted may relieve some of your heart failure symptoms without open-heart surgery and you may be able to stop some medications.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
Surgery = Operativer Eingriff
</note><note annotates="Glossary" from="MedDRA 26.0">Heart failure = Kardiales Versagen
Surgery = Operativer Eingriff
</note></trans-unit>
			<trans-unit translate="no" id="367">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="368">
				<source>Usually, the pain after the implant procedure is much less than open- heart surgery and your stay in the hospital is usually much shorter.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Pain = Schmerz
Surgery = Operativer Eingriff
</note><note annotates="Glossary" from="MedDRA 26.0">Pain = Schmerz
Surgery = Operativer Eingriff
</note></trans-unit>
			<trans-unit translate="no" id="369">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="370">
				<source>The recovery time can be faster  and there is little scarring.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Scarring = Narben
</note><note annotates="Glossary" from="MedDRA 26.0">Scarring = Narben
</note></trans-unit>
			<trans-unit translate="no" id="371">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="372">
				<source>There is no guarantee that you will personally benefit from participation in this study.</source>
			</trans-unit>
			<trans-unit translate="no" id="373">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="374">
				<source>However, it is possible that the experience gained from the study can help future patients.</source>
			</trans-unit>
			<trans-unit translate="yes" id="375">
				<source>ALTERNATIVE TREATMENT</source>
			</trans-unit>
			<trans-unit translate="yes" id="376">
				<source>If you choose not to participate in this study at this time, your doctor will discuss alternative treatments with you.</source>
			</trans-unit>
			<trans-unit translate="no" id="377">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="378">
				<source>Treatment options may include additional medication, implantation of FDA approved devices, the use of drugs to prevent the occurrence of symptoms, or not having any treatment at all.</source>
			</trans-unit>
			<trans-unit translate="yes" id="379">
				<source>Your doctor will explain the benefits and risks associated with the implantation of the Atrial Flow Regulator and the sham procedure, as well as the alternative treatments to you.</source>
			</trans-unit>
			<trans-unit translate="no" id="380">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="381">
				<source>Please ask your doctor if you have any questions.</source>
			</trans-unit>
			<trans-unit translate="yes" id="382">
				<source>If you do not wish to take part in the study, you will receive the established treatment/ one of the alternative treatments mentioned above.</source>
			</trans-unit>
			<trans-unit translate="no" id="383">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="384">
				<source>No disadvantage of any kind shall arise for you.</source>
			</trans-unit>
			<trans-unit translate="yes" id="385">
				<source>COSTS AND REIMBURESMENT OF EXPENSES</source>
			</trans-unit>
			<trans-unit translate="no" id="386">
				<source><ph id="1">&lt;bookmarkStart number="8" w:name="_Hlk85658195"/&gt;</ph></source>
			</trans-unit>
			<trans-unit translate="yes" id="387">
				<source>You will not be billed for the study device<ph id="1">&lt;bookmarkStart number="9" w:name="_Hlk112413606"/&gt;</ph> or implantation of the study device<ph id="2">&lt;bookmarkEnd number="9"/&gt;</ph>; however, your insurance will be billed for any routine care (standard of care) that is given to you.</source>
			</trans-unit>
			<trans-unit translate="no" id="388">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="389">
				<source>You may be required to pay deductibles or any co-payments that are associated with your insurance.</source>
			</trans-unit>
			<trans-unit translate="no" id="390">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="391">
				<source>Some of the tests that are done as part of this study may not be covered by your insurance.</source>
			</trans-unit>
			<trans-unit translate="no" id="392">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="393">
				<source>You should check with your insurance company to determine what is and what is not covered before participating in this study.</source>
			</trans-unit>
			<trans-unit translate="no" id="394">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="395">
				<source><ph id="1">&lt;bookmarkStart number="10" w:name="_Hlk112413672"/&gt;</ph>The sponsor will cover the cost of assessments and procedures required only for this study<bpt id="2">&lt;cf font="Calibri" asiantextfont="Calibri" complexscriptsfont="Calibri" size="11" complexscriptssize="11"&gt;</bpt>.<ept id="2">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="396">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>PAYMENTS<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="397">
				<source>After each office visit completed, you will receive a $75 stipend.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Office visit = Sprechstundenbesuch
</note><note annotates="Glossary" from="MedDRA 26.0">Office visit = Sprechstundenbesuch
</note></trans-unit>
			<trans-unit translate="yes" id="398">
				<source>If the total payment you receive from Northwell Health, during this year, is equal to $600 or more, the payment is required to be reported to the IRS.</source>
			</trans-unit>
			<trans-unit translate="no" id="399">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="400">
				<source>While this study may not pay $600, if you participate in other Northwell Health studies, it is possible your payment could end up totaling $600.</source>
			</trans-unit>
			<trans-unit translate="no" id="401">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="402">
				<source>If this occurs, the payment you receive will be reported to the IRS.</source>
			</trans-unit>
			<trans-unit translate="no" id="403">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="404">
				<source>In this case, you will be issued a 1099 form and be required to provide your social security at that time for reporting purposes.</source>
			</trans-unit>
			<trans-unit translate="no" id="405">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="406">
				<source>You will also be responsible for reporting this income while filing your tax return.</source>
			</trans-unit>
			<trans-unit translate="no" id="407">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="408">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on"&gt;</bpt>INJURY<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
</note><note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
</note></trans-unit>
			<trans-unit translate="yes" id="409">
				<source>If you have an injury from the study device, the reasonable medical expenses required to treat such injury or illness may be reimbursed by the study sponsor.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
Illness = Leiden
</note><note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
Illness = Leiden
</note></trans-unit>
			<trans-unit translate="no" id="410">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="411">
				<source>The coverage for such injury or illness is only available if the principal investigator and study sponsor have decided that the injury/illness is directly related to the study device, or properly performed procedures that you would not have undergone but for your participation in this study and is not the result of a pre-existing condition or underlying illness, whether or not previously diagnosed, or the normal progression of your disease, or the improper actions of the study doctor or institution.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
Illness = Leiden
</note><note annotates="Glossary" from="MedDRA 26.0">Injury = Verletzung
Illness = Leiden
</note></trans-unit>
			<trans-unit translate="no" id="412">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="413">
				<source>If you are injured by the study, contact the study doctor immediately.</source>
			</trans-unit>
			<trans-unit translate="no" id="414">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="415">
				<source>The study doctor will treat you or refer you for treatment.</source>
			</trans-unit>
			<trans-unit translate="yes" id="416">
				<source><ph id="1">&lt;bookmarkStart number="11" w:name="_Hlk112413834"/&gt;</ph>No other compensation will be offered by the sponsor or Northwell, including for things such as lost wages or discomfort.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Discomfort = Unbehagen
</note><note annotates="Glossary" from="MedDRA 26.0">Discomfort = Unbehagen
</note></trans-unit>
			<trans-unit translate="no" id="417">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="418">
				<source>You are not waiving any legal right to seek additional compensation through the courts by signing this form.</source>
			</trans-unit>
			<trans-unit translate="yes" id="419">
				<source>VOLUNTARY PARTICIPATION IN STUDY</source>
			</trans-unit>
			<trans-unit translate="yes" id="420">
				<source>Your participation in the clinical study is entirely voluntary.</source>
			</trans-unit>
			<trans-unit translate="no" id="421">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="422">
				<source>It is your choice whether to participate or not.</source>
			</trans-unit>
			<trans-unit translate="no" id="423">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="424">
				<source>If you decide not to take part or if you want to stop your participation at any time your standard treatment will be continued.</source>
			</trans-unit>
			<trans-unit translate="no" id="425">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="426">
				<source>There will be no penalty or loss of benefits to which you are otherwise entitled and there will be no effect on your access to medical care.</source>
			</trans-unit>
			<trans-unit translate="yes" id="427">
				<source>If you do choose to participate, you will be asked to sign an informed consent form.</source>
			</trans-unit>
			<trans-unit translate="no" id="428">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="429">
				<source>Even after you have signed the informed consent you may stop participating without a reason at any time you choose.</source>
			</trans-unit>
			<trans-unit translate="no" id="430">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="431">
				<source>In case you decide to stop participating in the study it is necessary to inform the study doctor right away.</source>
			</trans-unit>
			<trans-unit translate="no" id="432">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="433">
				<source>Once the investigator has received this information, they will probably ask you for a final examination visit.</source>
			</trans-unit>
			<trans-unit translate="no" id="434">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="435">
				<source>Thereafter, no further data will be collected.</source>
			</trans-unit>
			<trans-unit translate="no" id="436">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="437">
				<source>The data recorded up to this point will be evaluated for purposes of this study.</source>
			</trans-unit>
			<trans-unit translate="no" id="438">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="439">
				<source>Upon discontinuation of the study, please discuss your future medical treatment with your doctor.</source>
			</trans-unit>
			<trans-unit translate="yes" id="440">
				<source>If new information during the clinical study is obtained that may affect your decision to further participate, you will be told about this new information and given the chance to change your mind at any time.</source>
			</trans-unit>
			<trans-unit translate="no" id="441">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="442">
				<source>The study doctor may also end your participation at any time if the doctor thinks it’s in your best interest.</source>
			</trans-unit>
			<trans-unit translate="no" id="443">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="444">
				<source>The sponsor and authorities responsible for medical devices also have the right to terminate your participation.</source>
			</trans-unit>
			<trans-unit translate="yes" id="445">
				<source>During implantation it may become apparent that the Atrial Flow Regulator is not suitable for you and therefore you will not be included in this study and your participation will end.</source>
			</trans-unit>
			<trans-unit translate="no" id="446">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="447">
				<source>COLLECTION, PROCESSING AND PRIVATE POLICY OF STUDY DATA</source>
			</trans-unit>
			<trans-unit translate="yes" id="448">
				<source>If you decide to participate in this study, your personal data and medical records will be collected and saved for study purposes by the investigating doctor and medical staff.</source>
			</trans-unit>
			<trans-unit translate="no" id="449">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="450">
				<source>Your data will be treated confidentially.</source>
			</trans-unit>
			<trans-unit translate="no" id="451">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="452">
				<source>The sponsor will make every effort to protect the confidentiality of your data to the extent permitted by law, however complete privacy and confidentiality cannot be guaranteed as there may be conditions where records could be released.</source>
			</trans-unit>
			<trans-unit translate="no" id="453">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="454">
				<source>Your data will be deidentified, which means that all information about you will be deleted and replaced by codes before it is entered into a computer database.</source>
			</trans-unit>
			<trans-unit translate="no" id="455">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="456">
				<source>To ensure that the study is carried out properly, it may be necessary that representatives from the FDA or other agencies that monitor medical devices may view your data and original medical records.</source>
			</trans-unit>
			<trans-unit translate="no" id="457">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="458">
				<source>With your consent to participate in the study you agree that representatives of both the sponsor and FDA or other regulatory agencies including Institutional Review Boards (IRBs) or Ethic Committees (EC), who monitor medical product safety may  see your medical records to ensure the proper conduct of the study.</source>
			</trans-unit>
			<trans-unit translate="no" id="459">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="460">
				<source>Core labs and contract research organizations assisting with the study may also have access to your data.</source>
			</trans-unit>
			<trans-unit translate="yes" id="461">
				<source>A description of this clinical trial will be available on <bpt id="1">&lt;hyperlink Id="1" tkn="17362"&gt;</bpt>http://www.ClinicalTrials.gov<ept id="1">&lt;/hyperlink&gt;</ept>, as required by U.S. Law.</source>
			</trans-unit>
			<trans-unit translate="no" id="462">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="463">
				<source>This Web site will not include information that can identify you.</source>
			</trans-unit>
			<trans-unit translate="no" id="464">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="465">
				<source>At most, the Web site will include a summary of the results.</source>
			</trans-unit>
			<trans-unit translate="no" id="466">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="467">
				<source>You can search this Web site at any time.</source>
			</trans-unit>
			<trans-unit translate="yes" id="document.xml.1">
				<source>http://www.clinicaltrials.gov/</source>
			</trans-unit>
			<trans-unit translate="yes" id="468">
				<source>The results from this study may be published in scientific journals or forwarded to authorities for medical surveillance worldwide.</source>
			</trans-unit>
			<trans-unit translate="no" id="469">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="470">
				<source>In these cases, your data is marked with a patient code number.</source>
			</trans-unit>
			<trans-unit translate="no" id="471">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="472">
				<source>Only the above-mentioned persons (national or international regulatory authorities, representatives of the sponsor), you, your study doctor and their medical staff can match your identity information to the recorded data.</source>
			</trans-unit>
			<trans-unit translate="no" id="473">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="474">
				<source>The sponsor may use the data collected in this study for future unspecified medical research purposes.</source>
			</trans-unit>
			<trans-unit translate="yes" id="475">
				<source>Whom to Contact</source>
			</trans-unit>
			<trans-unit translate="yes" id="476">
				<source>During this clinical trial, if you have any further questions, concerns, complaints, or research- related injuries connected to your participation, please contact the Investigator (Study Doctor) below.</source>
			</trans-unit>
			<trans-unit translate="yes" id="477">
				<source>If you have questions concerns, complaints or for information concerning the rights of research subjects, please contact:</source>
			</trans-unit>
			<trans-unit translate="yes" id="478">
				<source>You will be informed in a timely manner of any relevant information pertaining to this clinical study.</source>
			</trans-unit>
			<trans-unit translate="yes" id="479">
				<source>Your participation in this clinical investigation is voluntary.</source>
			<note annotates="Glossary" from="MedDRA 26.0">Investigation = Untersuchung
</note><note annotates="Glossary" from="MedDRA 26.0">Investigation = Untersuchung
</note></trans-unit>
			<trans-unit translate="no" id="480">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="481">
				<source>Your decision whether to participate will not prejudice your future care with this institution.</source>
			</trans-unit>
			<trans-unit translate="no" id="482">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="483">
				<source>If you decide to participate, you are free to stop participation at any time without any consequences.</source>
			</trans-unit>
			<trans-unit translate="no" id="484">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="485">
				<source>You will be given a copy of this signed form to keep.</source>
			</trans-unit>
			<trans-unit translate="yes" id="486">
				<source>I have read and understand the above statements and voluntarily consent to participate in this study.</source>
			</trans-unit>
			<trans-unit translate="yes" id="487">
				<source>Print Name of Subject</source>
			</trans-unit>
			<trans-unit translate="yes" id="488">
				<source>Signature of Subject</source>
			</trans-unit>
			<trans-unit translate="yes" id="489">
				<source>Date</source>
			</trans-unit>
			<trans-unit translate="yes" id="490">
				<source>Subject consented by</source>
			</trans-unit>
			<trans-unit translate="yes" id="491">
				<source>Signature</source>
			</trans-unit>
			<trans-unit translate="yes" id="492">
				<source>Date</source>
			</trans-unit>
			<trans-unit translate="yes" id="493">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on" size="12" underlinestyle="single"&gt;</bpt>Northwell Institutionally Required Witness Signature<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="494">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>__________________________________________<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="495">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Printed name of witness<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="496">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>__________________________________________</source>
			</trans-unit>
			<trans-unit translate="no" id="497">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="no" id="498">
				<source>______________<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="499">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>Signature of witness</source>
			</trans-unit>
			<trans-unit translate="no" id="500">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="yes" id="501">
				<source>Date<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="502">
				<source><bpt id="1">&lt;cf size="12"&gt;</bpt>(Note:</source>
			</trans-unit>
			<trans-unit translate="no" id="503">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="504">
				<source>A witness can be a member of the research team, but cannot be the same person signing consent as the investigator)<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="505">
				<source><ph id="1">&lt;br w:type="page"/&gt;</ph></source>
			</trans-unit>
			<trans-unit translate="yes" id="506">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14" underlinestyle="single"&gt;</bpt>AUTHORIZATION TO USE AND DISCLOSE PROTECTED HEALTH INFORMATION<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="507">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>I also agree to permit Northwell Health Human Research Protection Program, my doctors, and my other health care providers to disclose health information in my medical records to the Researchers, Occlutech, and the FDA or other regulatory authorities for the purposes described below.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="508">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>The health information that may be used and disclosed includes:<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="509">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>All information collected during the research as described in the Informed Consent Form; and<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="510">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Health information in my medical records that is relevant to the research described in the Informed Consent Form.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="511">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>The Researchers may:<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="512">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Use and share my health information to conduct the research;<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="513">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Disclose my health information to the sponsor of research, Occlutech and its agents;<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="514">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Disclose my health information as required by law;<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="515">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Disclose my health information to representatives of government organizations and other persons who are required to watch over the safety and effectiveness of medical products and therapies and the conduct of research; and representatives of Northwell Health’s Human Research Protection Program (the group of people who oversee human subjects research).<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="516">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Remove from my health information, my name and other information that could be used to identify me.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="517">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>OCCLUTECH may:<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="518">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Use and share my health information to conduct the research;<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="519">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Disclose my health information as described in the Informed Consent;<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="520">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Disclose my health information as required by law;<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="521">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Disclose my health information to representatives of government organizations and other persons who are required to watch over the safety and effectiveness of medical products and therapies and the conduct of research; and<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="522">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Remove from my health information my name and other information that could be used to identify me.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="523">
				<source><bpt id="1">&lt;cf bold="on" size="14" complexscriptssize="14"&gt;</bpt>Once information that could be used to identify me has been removed, <ept id="1">&lt;/cf&gt;</ept><bpt id="2">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>the information that remains is no longer subject to this Authorization and may be used and disclosed by the Researchers and Occlutech as permitted by law.<ept id="2">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="524">
				<source><bpt id="1">&lt;cf bold="on" size="14" complexscriptssize="14"&gt;</bpt>Once my health information has been disclosed to a third party, <ept id="1">&lt;/cf&gt;</ept><bpt id="2">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>federal privacy laws may no longer protect it from further disclosure.</source>
			</trans-unit>
			<trans-unit translate="no" id="525">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="526">
				<source>However, the Researchers and Occlutech agree to protect my health information by using and disclosing it only as permitted by me in this Authorization and the Informed Consent.</source>
			</trans-unit>
			<trans-unit translate="no" id="527">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="528">
				<source>Also, no publication about the research will reveal my identity without my specific written permission.</source>
			</trans-unit>
			<trans-unit translate="no" id="529">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="530">
				<source>These limitations continue even if I revoke (take back) this Authorization.<ept id="2">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="531">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Please note that:<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="532">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>You do not have to sign this Authorization, but if you do not, you will not be allowed to participate in the research.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="533">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>However, if you revoke this Authorization, you will no longer be allowed to participate in the research.</source>
			</trans-unit>
			<trans-unit translate="no" id="534">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="535">
				<source>Also, even if you revoke this Authorization, the information already obtained by the Researchers and Occlutech may be used and disclosed as permitted by the Authorization and the Informed Consent.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="536">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>While the research is in progress, you will not be allowed to see your health information that is created or collected in the course of the research.</source>
			</trans-unit>
			<trans-unit translate="no" id="537">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="538">
				<source>After the research is finished, however, you may see this information as described in the (hospital/clinical trial site}’s Notice of Information practices.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="539">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>This Authorization will be good until December 31, 2070.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="540">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>You will be given a copy of this Authorization after you have signed it.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="541">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Print Name of Subject<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="542">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Signature of Subject<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="543">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Date<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="544">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Signature of Witness (if required)<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="545">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Date<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="546">
				<source><ph id="1">&lt;br w:type="page"/&gt;</ph><bpt id="2">&lt;cf bold="on" size="14" complexscriptssize="14"&gt;</bpt>AUTHORIZATION TO USE AND DISCLOSE PROTECTED HEALTH INFORMATION<ept id="2">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="547">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>The following sections provide a specific description of how your information will be used and disclosed if you participate in this research study.</source>
			</trans-unit>
			<trans-unit translate="no" id="548">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="549">
				<source>By signing and dating this form, you are authorizing such access.</source>
			</trans-unit>
			<trans-unit translate="no" id="550">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="551">
				<source>If you do not sign and date this form to authorize access, you will not be able to participate in this research study.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="552">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>This research study may be performed only by collecting and using your medical information.</source>
			</trans-unit>
			<trans-unit translate="no" id="553">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="554">
				<source>Your study records will be kept as confidential as possible.</source>
			</trans-unit>
			<trans-unit translate="no" id="555">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="556">
				<source>Only a number and your initials will be used to identify you.</source>
			</trans-unit>
			<trans-unit translate="no" id="557">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="558">
				<source>You will not be personally identified in any reports or publications that may result from this research study.</source>
			</trans-unit>
			<trans-unit translate="no" id="559">
				<source> <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="560">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Because of the research goals of this study, however, your study records cannot be kept completely confidential.</source>
			</trans-unit>
			<trans-unit translate="no" id="561">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="562">
				<source>The Sponsor of this study is Occlutech, Inc. <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="563">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>The study personnel, the Sponsor, Representatives from Northwell Health’s Human Research Protection Program (the group of people that oversee research at this institution), its agents, and Cardiovascular Research Foundation (CRF) will need to review the medical information collected from you for use in this study to accurately record information for this study.</source>
			</trans-unit>
			<trans-unit translate="no" id="564">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="565">
				<source>In addition, to review the study findings, the U.S. FDA, the IRB, and other regulatory agencies may review your medical records.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="566">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>The medical information that will be collected from you if you participate in the study includes the following:<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="567">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Information obtained from procedures to determine your eligibility to participate in the study, including a routine medical history, physical examination, and blood and urine tests.<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Physical examination = Koerperliche Untersuchung
</note><note annotates="Glossary" from="MedDRA 26.0">Physical examination = Koerperliche Untersuchung
</note></trans-unit>
			<trans-unit translate="yes" id="568">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Information that is created or collected from you during your participation in the study, including the results of the blood and urine tests and any other procedures performed during the study.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="569">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Information contained in your underlying medical records related to your medical history and treatment.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="570">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>The above information may identify you by name, address, telephone number, social security number, health plan number, study number, date of birth, dates relating to various medical procedures, and/or other identifying information.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="571">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>If you sign and date this form and you participate in the study, the study personnel will be authorized to use the information described above to carry out the purposes of the research study.</source>
			</trans-unit>
			<trans-unit translate="no" id="572">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="573">
				<source>The study personnel will also be authorized to disclose the relevant information described above to the following parties involved in the research study:<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="574">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Occlutech, CRF, or other agents designated by Occlutech to collect or review study data for verification of study procedures and/or adverse event (bad side effect) reporting.<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">Adverse event = Unerwuenschtes Ereignis
</note><note annotates="Glossary" from="MedDRA 26.0">Adverse event = Unerwuenschtes Ereignis
</note></trans-unit>
			<trans-unit translate="yes" id="575">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>The IRB or that oversees the research study at your site.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="576">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Government regulatory agencies including the FDA.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="577">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Clinical study recruitment company, if you were referred to the study by such a company, for analytical purposes and so they may be compensated.</source>
			</trans-unit>
			<trans-unit translate="no" id="578">
				<source> <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="579">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Representatives from Northwell Health’s Human Research Protection Program (the group of people that oversee research at this institution)<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="580">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Once your information is disclosed to the study sponsors, its agents, the IRB/IEC, or government agencies as described above, there is a potential that your medical information will be re-disclosed and will no longer be protected by U.S. federal privacy regulations.</source>
			</trans-unit>
			<trans-unit translate="no" id="581">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="582">
				<source>In addition to disclosures to the entities identified above, CRF may further electronically disclose your coded health information to others involved in the research study, such as the following:<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="583">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Laboratories or offsite testing facilities for clinical tests for safety and immune responses as required by study protocols.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="584">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Approved offsite storage facilities or cloud service providers to meet study record retention and storage requirements.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="585">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>The study Sponsor Occlutech, who directs the medical research studies.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="586">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Other third parties contracted by CRF and/or Occlutech to provide services related to studies and reporting of confirmed COVID-19 infections or test results to public health authorities.<ept id="1">&lt;/cf&gt;</ept></source>
			<note annotates="Glossary" from="MedDRA 26.0">COVID-19 = COVID-19
</note><note annotates="Glossary" from="MedDRA 26.0">COVID-19 = COVID-19
</note></trans-unit>
			<trans-unit translate="yes" id="587">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>The study data may be transferred to other countries for processing, including countries not covered by data protection legislation.</source>
			</trans-unit>
			<trans-unit translate="no" id="588">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="589">
				<source>The laws of state where you live may provide further protection.</source>
			</trans-unit>
			<trans-unit translate="no" id="590">
				<source> <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="591">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>While the study is in progress, your access to your study records will be temporarily suspended.</source>
			</trans-unit>
			<trans-unit translate="no" id="592">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="593">
				<source>You will be able to access your information when the research study is completed.</source>
			</trans-unit>
			<trans-unit translate="no" id="594">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="595">
				<source>You have the right to see and copy the medical information collected from you in the course of the study for as long as that information is maintained by the study personnel and other entities participant to federal privacy regulation.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="596">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Study data, including your coded medical information, may be used and shared by the Sponsor.</source>
			</trans-unit>
			<trans-unit translate="no" id="597">
				<source> <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="598">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>You may withdraw your authorization at any time by sending a written request to the study doctor listed on page one of this informed consent.</source>
			</trans-unit>
			<trans-unit translate="no" id="599">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="600">
				<source>You have the right to require that any previously retained samples are destroyed.</source>
			</trans-unit>
			<trans-unit translate="no" id="601">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="602">
				<source>If you withdraw your authorization, data collected prior to your withdrawal may still be processed along with other data collected as part of the study.</source>
			</trans-unit>
			<trans-unit translate="no" id="603">
				<source> <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="604">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Normally no new information will be collected for the study database unless you specifically authorize that.</source>
			</trans-unit>
			<trans-unit translate="no" id="605">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="606">
				<source>However, the law does require that any side affects you may suffer are documented and reported.</source>
			</trans-unit>
			<trans-unit translate="no" id="607">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="608">
				<source>To complete the study findings, your long-term health status may also be obtained from public sources.</source>
			</trans-unit>
			<trans-unit translate="no" id="609">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="610">
				<source>In California and any other state that requires an expiration date, the Authorization will expire 50 years after you sign and date this authorization document.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="611">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>I understand that I have the right to refuse to sign and date this authorization, which will result in my inability to participate in the study.</source>
			</trans-unit>
			<trans-unit translate="no" id="612">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="613">
				<source>You will receive a copy of this authorization after you have signed and dated it.</source>
			</trans-unit>
			<trans-unit translate="no" id="614">
				<source> <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="615">
				<source><ph id="1">&lt;br w:type="page"/&gt;</ph></source>
			</trans-unit>
			<trans-unit translate="no" id="616">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>_____________________________________<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="617">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Printed Name of Participant <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="618">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>_____________________________________</source>
			</trans-unit>
			<trans-unit translate="no" id="619">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="no" id="620">
				<source>__________________<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="621">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Signature of Participant</source>
			</trans-unit>
			<trans-unit translate="no" id="622">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="yes" id="623">
				<source>Date<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="624">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>I have presented the authorization and answered the participant’s questions.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="625">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>I will give the participant a copy of this signed and dated authorization.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="626">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>____________________________________________________________<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="627">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Presenter (Study Doctor/Delegate)</source>
			</trans-unit>
			<trans-unit translate="no" id="628">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="yes" id="629">
				<source>Signature</source>
			</trans-unit>
			<trans-unit translate="no" id="630">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="yes" id="631">
				<source>Date<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="632">
				<source><bpt id="1">&lt;cf bold="on" complexscriptsbold="on" size="14" complexscriptssize="14"&gt;</bpt>WITNESS SIGNATURE FOR PARTICIPANTS WHO CANNOT READ <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="633">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>The study participant has indicated that he/she is unable to read.</source>
			</trans-unit>
			<trans-unit translate="no" id="634">
				<source> </source>
			</trans-unit>
			<trans-unit translate="yes" id="635">
				<source>This authorization form has been read to the participant by a member of the study staff, discussed with the subject by a member of the study staff, and the participant has been given an opportunity to ask questions of the study staff.<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="636">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>____________________________________<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="637">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Printed Name of Impartial Witness <ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="no" id="638">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>____________________________________</source>
			</trans-unit>
			<trans-unit translate="no" id="639">
				<source>	</source>
			</trans-unit>
			<trans-unit translate="no" id="640">
				<source>__________<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="641">
				<source><bpt id="1">&lt;cf size="14" complexscriptssize="14"&gt;</bpt>Signature of Impartial Witness</source>
			</trans-unit>
			<trans-unit translate="no" id="642">
				<source> 	</source>
			</trans-unit>
			<trans-unit translate="yes" id="643">
				<source>Date<ept id="1">&lt;/cf&gt;</ept></source>
			</trans-unit>
			<trans-unit translate="yes" id="644">
				<source>Page <ph id="1">&lt;field Id="1" text="PAGE"/&gt;</ph> of <ph id="2">&lt;field Id="2" text="NUMPAGES"/&gt;</ph></source>
			</trans-unit>
		</body>
	</file>
</xliff>